The Role of Immune Checkpoint Inhibitors in Cancer Therapy

Lectura recomendada por el Lectura recomendada por el Dr. Santiago Fontes.

Conferencia 2024: “Inmunoterapia contra el cáncer; un nuevo paradigma”

Autores: Shuzhen Tana, Dongpei Lib, Xiao Zhu.
Fuente: Clin. Pract. 2023, 13, 22–40

The Role of Immune Checkpoint Inhibitors in Cancer Therapy

04.-The_Role_of_Immune_Checkpoint_Inhibitors_in_Cancer

admin2025-07-12T16:53:10-03:00Artículos recomendados, Inmunoterapia contra el cáncer; un nuevo paradigma|

Artículos relacionados

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer

The Promise of Combining Radiation Therapy With Immunotherapy

The Promise of Combining Radiation Therapy With Immunotherapy

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Combination of SABR With Anti-PD-1 in Oligoprogressive Non-Small Cell Lung Cancer and Melanoma: Results of a Prospective Multicenter Observational Study

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy